Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α

Cell

Volumn 110, Issue 6, 2002, Pages 763-773

  Garrett, Thomas P J ^a   McKern, Neil M ^a,b   Lou, Meizhen ^a   Elleman, Thomas C ^b   Adams, Timothy E ^a,b   Lovrecz, George O ^a,b   Zhu, Hong Jian ^a   Walker, Francesca ^a   Frenkel, Morry J ^a,b   Hoyne, Peter A ^a,b   Jorissen, Robert N ^a   Nice, Edouard C ^a   Burgess, Antony W ^a   Ward, Colin W ^a,b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIMERIZATION; HUMAN; HUMAN CELL; MOLECULE; MOUSE; MUTAGENESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; SEQUENCE ALIGNMENT;

ANIMALIA;

EID: 18644370411     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)00940-6     Document Type: Article

References (57)

1. Aritomi M., Kunishima N., Okamoto T., Kuroki R., Ota Y., Morikawa K. Atomic structure of the GCSF-receptor complex showing a new cytokine-receptor recognition. Nature. 401:1999;713-715.
2. Bajaj M., Waterfield M.D., Schlessinger J., Taylor W.R., Blundell T. On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors. Biochim. Biophys. Acta. 916:1987;220-226.
3. Banner D.W., D'Arcy A., Janes W., Gentz R., Schoenfeld H.J., Broger C., Loetscher H., Lesslauer W. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex. implications for TNF receptor activation Cell. 73:1993;431-445.
4. Barnham K.J., Torres A.M., Alewood D., Alewood P.F., Domagala T., Nice E.C., Norton R.S. Role of the 6-20 disulfide bridge in the structure and activity of epidermal growth factor. Protein Sci. 7:1998;1738-1749.
5. Brizzard B.L., Chubet R.G., Vizard D.L. Immunoaffinity purification of FLAG epitope-tagged bacterial alkaline phosphatase using a novel monoclonal antibody and peptide elution. Biotechniques. 16:1994;730-735.
6. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jian-Sheng Jiang J.S., Kuszewski J., Nilges M., Navraj S.et al. Crystallography & NMR systems. a new software suite for macromolecular structure determination Acta Crystallogr. D. 54:1998;905-921.
7. Cooke R.M., Wilkinson A.J., Baron M., Pastore A., Tappin M.J., Campbell I.D., Gregory H., Sheard B. The solution structure of human epidermal growth factor. Nature. 327:1987;339-341.
8. Cowtan K. Dm. an automated procedure for phase improvement by density modification Joint CCP4 and ESF-EACBM Newslett. Prot. Crystallogr. 31:1994;34-38.
9. Degenhardt M., Weber W., Eschenburg S., Dierks K., Funari S.S., Rapp G., Betzel C. Crystallization and preliminary X-ray crystallographic analysis of the EGF receptor ectodomain. Acta Crystallogr. D54:1998;999-1001.
10. De La Fortelle E., Bricogne G. Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. Methods Enzymol. 276:1996;472-494.
11. de Vos A.M., Ultsch M., Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor. crystal structure of the complex Science. 255:1992;306-312.
12. Elleman T.C., Domagala T., McKern N.M., Nerrie M., Lonnqvist B., Adams T.E., Lewis J., Lovrecz G.O., Hoyne P.A., Richards K.M.et al. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain. Biochemistry. 40:2001;8930-8939.
13. Garrett T.P.J., McKern N.M., Lou M., Frenkel M.J., Bentley J.D., Lovrecz G.O., Elleman T.C., Cosgrove L.J., Ward C.W. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature. 394:1998;395-399.
14. Groenen L.C., Nice E.C., Burgess A.W. Structure-function relationships for the EGF/TGF-α family of mitogens. Growth Factors. 11:1994;235-257.
15. Gunther N., Betzel C., Weber W. The secreted form of the epidermal growth factor receptor. J. Biol. Chem. 265:1990;22082-22085.
16. Harvey T.S., Wilkinson A.J., Tappin M.J., Cooke R.M., Campbell I.D. The solution structure of human transforming growth factor α Eur. J. Biochem. 198:1991;555-562.
17. Jacobsen N.E., Abadi N., Sliwkowski M.X., Reilly D., Skelton N.J., Fairbrother W.J. High-resolution solution structure of the EGF-like domain of heregulin-α Biochemistry. 35:1996;3402-3417.
18. Jorissen R.N., Epa V.C., Treutlein H.R., Garrett T.P.J., Ward C.W., Burgess A.W. Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor. Protein Sci. 9:2000;310-324.
19. Kirsch T., Sebald W., Dreyer M.K. Crystal structure of the Bmp-2-Bria ectodomain complex. Nat. Struct. Biol. 7:2000;492-496.
20. Kobe B., Kajava A.V. The leucine-rich repeat recognition motif. Curr. Opin. Struct. Biol. 11:2001;725-732.
21. Kohda D., Inagaki F. Three-dimensional nuclear magnetic resonance structures of mouse epidermal growth factor in acidic and physiological pH solutions. Biochemistry. 31:1992;11928-11939.
22. Kohda D., Odaka M., Lax I., Kawasaki H., Suzuki K., Ullrich A., Schlessinger J., Inagaki F. A 40-kDa epidermal growth factor/transforming growth factor α-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor. J. Biol. Chem. 268:1993;1976-1981.
23. Kunishima N., Shimada Y., Tsuji Y., Sato T., Yamamoto M., Kumasaka T., Nakanishi S., Jingami H., Morikawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature. 407:2000;971-977.
24. Lax I., Johnson A., Howk R., Sap J., Bellot F., Winkler M., Ullrich A., Vennstrom B., Schlessinger J., Givol D. Chicken epidermal growth factor (EGF) receptor. cDNA cloning, expression in mouse cells, and differential binding of EGF and transforming growth factor alpha Mol. Cell. Biol. 8:1988;1970-1978.
25. Lax I., Bellot F., Howk R., Ullrich A., Givol D., Schlessinger J. Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules. EMBO J. 8:1989;421-427.
26. Lemmon M.A., Schlessinger J. Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem. Sci. 19:1994;459-463.
27. Lemmon M.A., Bu Z., Ladbury J.E., Zhou M., Pinchasi D., Lax I., Engelman D.M., Schlessinger J. Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J. 16:1997;281-294.
28. Lo Conte L., Chothia C., Janin J. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 285:1999;2177-2198.
29. Louie G.V., Yang W., Bowman M.E., Choe S. Crystal structure of the complex of diphtheria toxin with an extracellular fragment of its receptor. Mol. Cell. 1:1997;67-78.
30. Lu H.S., Chai J.J., Li M., Huang B.R., He C.H., Bi R.C. Crystal structure of human epidermal growth factor and its dimerization. J. Biol. Chem. 276:2001;34913-34917.
31. Montelione G.T., Wuthrich K., Nice E.C., Burgess A.W., Scheraga H.A. Solution structure of murine epidermal growth factor. determination of the polypeptide backbone chain-fold by nuclear magnetic resonance and distance geometry Proc. Natl. Acad. Sci. USA. 84:1987;5226-5230.
32. Moriki T., Maruyama H., Maruyama I.N. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J. Mol. Biol. 311:2001;1011-1026.
33. Moscatello D.K., Holgado-Madruga M., Godwin A.K., Ramirez G., Gunn G., Zoltick P.W., Biegel J.A., Hayes R.L., Wong A.J. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res. 55:1995;5536-5539.
34. Moy F.J., Li Y.C., Rauenbuehler P., Winkler M.E., Scheraga H.A., Montelione G.T. Solution structure of human type-α transforming growth factor determined by heteronuclear NMR spectroscopy and refined by energy minimization with restraints. Biochemistry. 32:1993;7334-7353.
35. erbB-4. EMBO J. 13:1994;3517-3523.
36. Ogiso H., Ishitani R., Nureki O., Fukai S., Yamanaka M., Kim J.-H., Saito K., Sakamoto A., Inoue M., Shirouzu M., Yokoyama S. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell. 110:2002;775-787. this issue,
37. Pellegrini L., Burke D.F., von Delft F., Mulloy B., Blundell T.L. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature. 407:2000;1029-1034.
38. Plotnikov A.N., Hubbard S.R., Schlessinger J., Mohammadi M. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell. 101:2000;413-424.
39. Riese D.J. II, Stern D.F. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays. 20:1998;41-48.
40. Schlessinger J., Plotnikov A.N., Ibrahimi O.A., Eliseenkova A.V., Yeh B.K., Yayon A., Linhardt R.J., Mohammadi M. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell. 6:2000;743-750.
41. Singer E., Landgraf R., Horan T., Slamon D., Eisenberg D. Identification of a heregulin binding site in HER3 extracellular domain. J. Biol. Chem. 47:2001;44266-44274.
42. Sorokin A., Lemmon M.A., Ullrich A., Schlessinger J. Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond. J. Biol. Chem. 269:1994;9752-9759.
43. Summerfield A.E., Hudnall A.K., Lukas T.J., Guyer C.A., Staros J.V. Identification of residues of the epidermal growth factor receptor proximal to residue 45 of bound epidermal growth factor. J. Biol. Chem. 271:1996;19656-19659.
44. Sundaresan S., Roberts P.E., King K.L., Sliwkowski M.X., Mather J.P. Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression. Endocrinology. 139:1998;4756-4764.
45. Tappin M.J., Cooke R.M., Fitton J.E., Campbell I.D. A high-resolution 1H-NMR study of human transforming growth factor α. Structure and pH-dependent conformational interconversion. Eur. J. Biochem. 179:1989;629-637.
46. Thiel D.J., Le Du M.-H., Walter R.L., D'Arcy A., Chene C., Fountoulakis M., Garotta G., Winkler F.K., Ealick S.E. Observation of an unexpected third receptor molecule in the crystal structure of human interferon-gamma receptor complex. Structure Fold Des. 8:2000;927-936.
47. Ullrich A., Coussens L., Hayflick J.S., Dull T.J., Gray A., Tam A.W., Lee J., Yarden Y., Libermann T.A., Schlessinger J.et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature. 309:1984;418-425.
48. Walker F., Hibbs M.L., Zhang H.H., Gonez L.J., Burgess A.W. Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3. Growth Factors. 16:1998;53-67.
49. Ward C.W., Garrett T.P.J. The relationship between the L1 and L2 domains of the insulin and epidermal growth factor receptors and leucine-rich repeat modules. BMC Bioinformatics. 2:2001;4.
50. Ward C.W., Hoyne P.A., Flegg R.H. Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor. Proteins. 22:1995;141-153.
51. Weber W., Wenisch E., Gunther N., Marnitz U., Betzel C., Righetti P.G. Protein microheterogeneity and crystal habits. the case of epidermal growth factor receptor isoforms as isolated in a multicompartment electrolyzer with isoelectric membranes J. Chromatogr. A. 679:1994;181-189.
52. Wiesmann C., Fuh G., Christinger H.W., Eigenbrot C., Wells J.A., de Vos A.M. Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell. 91:1997;695-704.
53. Wiesmann C., Ultsch M.H., Bass S.H., de Vos A.M. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature. 401:1999;184-188.
54. Woltjer R.L., Lukas T.J., Staros J.V. Direct identification of residues of the epidermal growth factor receptor in close proximity to the amino terminus of bound epidermal growth factor. Proc. Natl. Acad. Sci. USA. 89:1992;7801-7805.
55. Wu D.G., Wang L.H., Sato G.H., West K.A., Harris W.R., Crabb J.W., Sato J.D. Human epidermal growth factor (EGF) receptor sequence recognized by EGF competitive monoclonal antibodies. Evidence for the localization of the EGF-binding site. J. Biol. Chem. 264:1989;17469-17475.
56. Yarden Y. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities Eur. J. Cancer. 37:2001;S3-S8. (Suppl 4),
57. Yarden Y., Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2:2001;127-137.